- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: JNJ-26366821
Total 1085 results
-
Janssen Research & Development, LLCRecruitingWarm Autoimmune Hemolytic AnemiaUnited States, Israel, Korea, Republic of, Spain, Czechia, France, Brazil, China, United Kingdom, Malaysia, Hungary, Japan, Poland, Germany, Ukraine, Italy, Greece, Netherlands, Egypt
-
Janssen Research & Development, LLCTerminatedDermatitis, AtopicUnited States, Germany, Canada, Poland, Japan
-
Janssen Research & Development, LLCCompletedHealthy | Systemic Lupus ErythematosusUnited States, Spain, Romania, Taiwan, Belgium, Poland, Moldova, Republic of
-
Janssen Research & Development, LLCActive, not recruitingUrothelial CarcinomaFrance, United States, Korea, Republic of, Belgium, Poland, Taiwan, Turkey, Russian Federation, Spain, Italy, United Kingdom, Brazil, Belarus
-
Crucell Holland BVCompletedRespiratory Tract Infections | Respiratory Syncytial VirusesUnited States
-
Janssen Research & Development, LLCBristol-Myers SquibbCompletedArthroplasty, Replacement, KneeIsrael, Belgium, Italy, United States, Spain, Hungary, Portugal, Russian Federation, Japan, Turkey, Ukraine, Greece, Poland, Argentina, Brazil, Bulgaria, Canada, South Africa
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Testosterone Greater Than 150 ng/dLUnited States
-
Janssen Research & Development, LLCCompletedRespiratory Syncytial VirusesTaiwan, Belgium, United Kingdom, Argentina, Panama
-
Janssen-Cilag International NVCompletedHealthy Volunteers | PharmacokineticsBelgium
-
Johnson & Johnson Enterprise Innovation Inc.RecruitingCarcinoma, Non-small-Cell LungKorea, Republic of, Spain, United States, Germany
-
Janssen Research & Development, LLCCompletedArthritis, RheumatoidUnited Kingdom, United States, Spain, Germany, Poland
-
Janssen Research & Development, LLCActive, not recruitingHepatitis B, ChronicFrance, Belgium, Italy, United Kingdom, Poland, Spain, New Zealand, Taiwan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCRecruitingHemolytic Disease of the Fetus and NewbornIsrael, Brazil, Australia, United States, United Kingdom
-
Janssen Research & Development, LLCRecruitingPolyradiculoneuropathy, Chronic Inflammatory DemyelinatingUnited States, China, Taiwan, Korea, Republic of, Japan, France, Spain, Czechia, Poland, Greece, United Kingdom
-
Janssen Research & Development, LLCRecruitingMyasthenia GravisUnited States, Korea, Republic of, Japan, Taiwan, Denmark, Germany, Czechia, China, Spain, Belgium, Canada, Mexico, Poland, Italy, France, Australia, Sweden
-
Janssen Research & Development, LLCCompleted
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Pharmaceutica N.V., BelgiumCompleted
-
Janssen Research & Development, LLCBristol-Myers SquibbRecruitingAcute Coronary SyndromeTaiwan, Korea, Republic of, United States, Italy, South Africa, Belgium, Argentina, Israel, Malaysia, Romania, Serbia, China, Australia, Netherlands, United Kingdom, Denmark, Czechia, Hungary, Japan, France, Canada, Bulgaria, Spain, T... and more
-
Janssen Research & Development, LLCBristol Myers Squibb Company (BMS)RecruitingIschemic Stroke; Ischemic Attack, TransientItaly, United States, Hong Kong, Japan, Taiwan, Korea, Republic of, Israel, United Kingdom, Argentina, Belgium, New Zealand, Canada, Germany, Denmark, Mexico, Croatia, France, Australia, Brazil, China, Czechia, Hungary, Netherlands, S... and more
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple Myeloma | Previously Treated Amyloid Light-chain (AL) AmyloidosisBelgium, United States, United Kingdom, Spain, France, Netherlands
-
Janssen Research & Development, LLCRecruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, China, France, Denmark, Israel, Poland, Australia
-
Janssen Research & Development, LLCCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Spain, Germany
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedSleep Apnea, ObstructiveUnited States
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Janssen Research & Development, LLCRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, United States, Malaysia, Turkey
-
Janssen Sciences Ireland UCCompletedHepatitis BUnited States, Korea, Republic of, France, Belgium, Italy, Taiwan, United Kingdom, Thailand, Malaysia, China, Spain, Canada, Germany, Japan, Russian Federation, Turkey, Ukraine, Poland, Hong Kong
-
Janssen Research & Development, LLCRecruiting
-
Janssen Research & Development, LLCRecruitingNeoplasms | Myeloproliferative Disorders | Essential Thrombocythemia | MyelofibrosisUnited States, Spain, France, Canada
-
Merck Sharp & Dohme LLCRecruitingHepatic Impairment | Non-alcoholic SteatohepatitisUnited States
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, United Kingdom, Taiwan, Israel, Spain, Australia, France
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Scientific Affairs, LLCAvailable
-
Janssen Vaccines & Prevention B.V.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Pharmaceutical K.K.CompletedProstatic Neoplasms, Castration-ResistantJapan
-
Janssen Research & Development, LLCTerminatedAdvanced CancerUnited States
-
Janssen Research & Development, LLCTerminated
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Germany, Netherlands, Spain
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedMyelodysplastic Syndromes | Advanced or Refractory LeukemiaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Janssen Pharmaceutica N.V., BelgiumCompletedPharmacokinetics | Advanced Malignancies | Solid Malignancies | Protein Kinase Inhibitors | Maximum Tolerated Dose | Antineoplastic Protocols | Clinical Trial, Phase 1
-
Janssen Research & Development, LLCRecruitingHematological MalignanciesUnited States, Belgium, Korea, Republic of, China, Germany, Israel, Spain, Netherlands, Japan, France, Poland